Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Interventional × Random Allocation × Clear all

Phase

Phase 2 2 Phase NA 1 Phase 4 1 Phase 2/3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1

Interventions

Metformin 47 Dexamethasone 47 Cyclophosphamide 37 Saline Solution 36 Cytarabine 34 Cisplatin 30 Sodium Chloride 29 Bupivacaine 29 Zoledronic Acid 28 Letrozole 28 Propofol 26 Carboplatin 26 Docetaxel 25 Dexmedetomidine 25 Bevacizumab 25 Vincristine 24 Methotrexate 24 Fentanyl 24 Fluorouracil 23 Capecitabine 22 Doxorubicin 21 Rituximab 20 Prednisone 20 Paclitaxel 19 Morphine 19 Drug Therapy 19 Oxaliplatin 18 Granulocyte Colony-Stimulating Factor 18 Acetaminophen 18 Imiquimod 17

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02590315 2019-01-31

ProteusDonna

Centro di Riferimento per l'Epidemiologia e la Prev. Oncologica Piemonte

Phase 4 Unknown

92,000 enrolled

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡